Ascendis Pharma A (ASND) Inventory (2021 - 2026)

Ascendis Pharma A (ASND) has 6 years of Inventory data on file, last reported at $368.0 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 19.38% year-over-year to $368.0 million; the trailing twelve-month figure through Mar 2026 stood at $368.0 million (up 19.38% YoY), and the FY2025 full-year result was $351.0 million, up 9.7% from the prior year.
• Inventory advanced to $368.0 million in Q1 2026, from $351.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $368.0 million in Q1 2026 to a low of $103.7 million in Q1 2022.
• A 5-year average of $240.0 million and a median of $252.8 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory surged 96.39% in 2023 and gained 11.12% in 2025, its largest moves.
• Tracing ASND's Inventory over 5 years: stood at $133.3 million in 2022, then soared by 68.62% to $224.8 million in 2023, then soared by 40.52% to $315.9 million in 2024, then advanced by 11.12% to $351.0 million in 2025, then grew by 4.85% to $368.0 million in 2026.
• Business Quant data shows ASND's Inventory at $368.0 million in Q1 2026, $351.0 million in Q4 2025, and $353.1 million in Q3 2025.